Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET
Company Participants
Alex Lobo - Stern Investor Relations
Kevin Boyle Senior - Chief Executive Officer
Abhi Srivastava - Vice President, Technical Operations
Drew Deniger - Vice President, Research and Development
Mike Wong - Vice President, Finance
Conference Call Participants
Prakhar Agrawal - Cantor Fitzgerald
James Shin - Wells Fargo
Yale Jen - Laidlaw
Thomas Flaten - Lake Street Capital Markets
Operator
Good day and thank you for standing by. Welcome to the Alaunos Therapeutics Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]
Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Alex Lobo, with Stern Investor Relations. Please go ahead.
Alex Lobo
Thank you. Good morning. And welcome to the Alaunos Therapeutics third quarter 2022 financial results conference call and audio webcast. Please note that today’s webcast contains slides, which are available through the audio webcasting platform. A copy of the presentation will be available on our website after today’s call.
Earlier this morning, Alaunos issued a press release announcing financial results for the three months ended September 30, 2022. We encourage everyone to read today’s press release, as well as the Alaunos’ quarterly report on Form 10-Q for the quarter ended September 30, 2022, which was filed this morning with the SEC.
The company’s press release and quarterly report will also be available on the lanes website at alaunos.com. In addition, this conference call is being webcast to the Investor Relations section of the company’s website and will be archived there for future reference.
Please note that certain information discussed on today’s call covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Participants are cautioned that this conference call contains time sensitive information that is accurate only as of the date of this live broadcast, November 14, 2022.
Actual results could differ materially from those stated or implied by forward-looking statements made on today’s call due to risks and uncertainties associated with the company’s business. Information on potential risks and uncertainties are set forth in our most recent public filings with the SEC at sec.gov.
The company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this live webcast, except as may be required by applicable securities laws.